Candidate Selection, Timing of Listing, and Choice of Procedure for Lung Transplantation

Clinics in Chest Medicine

Volumn 32, Issue 2, 2011, Pages 199-211

  Kreider, Maryl ^a   Hadjiliadis, Denis ^a   Kotloff, Robert M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lung transplantation; Selection criteria; Techniques

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DYSPNEA; EMPHYSEMA; FIBROSING ALVEOLITIS; HUMAN; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; THORAX RADIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CYSTIC FIBROSIS; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES; LUNG TRANSPLANTATION; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; WAITING LISTS;

EID: 79954568875     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.02.001     Document Type: Review

References (85)

1. Christie J.D., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010, 29:1104-1118.
2. Yusen R.D., Shearon T.H., Qian Y., et al. Lung transplantation in the United States, 1999-2008. Am J Transplant 2010, 10:1047-1068.
3. Schachna L., Medsger T.A., Dauber J.H., et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006, 54:3954-3961.
4. Shitrit D., Amital A., Peled N., et al. Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation. Clin Transplant 2009, 23:178-183.
5. de Perrot M., Chernenko S., Waddell T.K., et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol 2004, 22:4351-4356.
6. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the pulmonary scientific council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006, 25:745-755.
7. Harringer W., Haverich A. Heart and heart-lung transplantation: standards and improvements. World J Surg 2002, 26:218-225.
8. Grannas G., Neipp M., Hoeper M.M., et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation 2008, 85:524-531.
9. Mahidhara R., Bastani S., Ross D.J., et al. Lung transplantation in older patients?. J Thorac Cardiovasc Surg 2008, 135:412-420.
10. Levine S.M. A survey of clinical practice of lung transplantation in North America. Chest 2004, 125:1224-1238.
11. Mason D.P., Thuita L., Nowicki E.R., et al. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg 2010, 139:765-773. e761.
12. Dusmet M., Winton T.L., Kesten S., et al. Previous intrapleural procedures do not adversely affect lung transplantation. J Heart Lung Transplant 1996, 15:249-254.
13. Detterbeck F.C., Egan T.M., Mill M.R. Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg 1995, 60:139-143.
14. Burns K.E., Keenan R.J., Grgurich W.F., et al. Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study. Ann Thorac Surg 2002, 73:1587-1593.
15. Hadjiliadis D., Sporn T.A., Perfect J.R., et al. Outcome of lung transplantation in patients with mycetomas. Chest 2002, 121:128-134.
16. Aris R.M., Gilligan P.H., Neuringer I.P., et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997, 155:1699-1704.
17. Dobbin C., Maley M., Harkness J., et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 2004, 56:277-282.
18. Hadjiliadis D., Steele M.P., Chaparro C., et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007, 26:834-838.
19. Aris R.M., Routh J.C., LiPuma J.J., et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001, 164:2102-2106.
20. Chaparro C., Maurer J., Gutierrez C., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001, 163:43-48.
21. Liou T.G., Adler F.R., Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005, 171:1053-1059.
22. Alexander B.D., Petzold E.W., Reller L.B., et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008, 8:1025-1030.
23. Murray S., Charbeneau J., Marshall B.C., et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008, 178:363-371.
24. Helmi M., Love R.B., Welter D., et al. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 2003, 123:800-808.
25. Nunley D.R., Ohori P., Grgurich W.F., et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998, 114:1321-1329.
26. Chalermskulrat W., Sood N., Neuringer I.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61:507-513.
27. Traver G.A., Cline M.G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979, 119:895-902.
28. Martinez F.J., Kotloff R. Prognostication in chronic obstructive pulmonary disease: implications for lung transplantation. Semin Respir Crit Care Med 2001, 22:489-498.
29. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
30. Martinez F.J., Han M.K., Andrei A.C., et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008, 178:491-499.
31. Hosenpud J.D., Bennett L.E., Keck B.M., et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998, 351:24-27.
32. De Meester J., Smits J.M., Persijn G.G., et al. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001, 20:518-524.
33. Charman S.C., Sharples L.D., McNeil K.D., et al. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002, 21:226-232.
34. Thabut G., Christie J.D., Ravaud P., et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008, 371:744-751.
35. Meyers B.F., Yusen R.D., Guthrie T.J., et al. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovasc Surg 2001, 122:10-17.
36. Senbaklavaci O., Wisser W., Ozpeker C., et al. Successful lung volume reduction surgery brings patients into better condition for later lung transplantation. Eur J Cardiothorac Surg 2002, 22:363-367.
37. Bavaria J.E., Pochettino A., Kotloff R.M., et al. Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1998, 115:9-17.
38. Travis W.D., Matsui K., Moss J., et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000, 24:19-33.
39. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199-203.
40. Daniil Z.D., Gilchrist F.C., Nicholson A.G., et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999, 160:899-905.
41. Flaherty K.R., Travis W.D., Colby T.V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164:1722-1727.
42. King T.E., Schwarz M.I., Brown K., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001, 164:1025-1032.
43. Nicholson A.G., Fulford L.G., Colby T.V., et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 166:173-177.
44. Gay S.E., Kazerooni E.A., Toews G.B., et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998, 157:1063-1072.
45. Lynch D.A., David Godwin J., Safrin S., et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005, 172:488-493.
46. Sumikawa H., Johkoh T., Colby T.V., et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 2008, 177:433-439.
47. Flaherty K.R., Thwaite E.L., Kazerooni E.A., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003, 58:143-148.
48. Mogulkoc N., Brutsche M.H., Bishop P.W., et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001, 164:103-108.
49. Collard H.R., King T.E., Bartelson B.B., et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:538-542.
50. Lama V.N., Flaherty K.R., Toews G.B., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003, 168:1084-1090.
51. Lederer D.J., Arcasoy S.M., Wilt J.S., et al. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:659-664.
52. Flaherty K.R., Mumford J.A., Murray S., et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003, 168:543-548.
53. Latsi P.I., du Bois R.M., Nicholson A.G., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003, 168:531-537.
54. Zappala C.J., Latsi P.I., Nicholson A.G., et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010, 35:830-836.
55. Swigris J.J., Swick J., Wamboldt F.S., et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009, 136:841-848.
56. Arcasoy S.M., Christie J.D., Ferrari V.A., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167:735-740.
57. Lettieri C.J., Nathan S.D., Barnett S.D., et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006, 129:746-752.
58. Hamada K., Nagai S., Tanaka S., et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007, 131:650-656.
59. Nadrous H.F., Pellikka P.A., Krowka M.J., et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005, 128:2393-2399.
60. Collard H.R., Moore B.B., Flaherty K.R., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007, 176:636-643.
61. Blivet S., Philit F., Sab J.M., et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001, 120:209-212.
62. Saydain G., Islam A., Afessa B., et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002, 166:839-842.
63. Cottin V., Le Pavec J., Prevot G., et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010, 35:105-111.
64. Cottin V., Nunes H., Brillet P.Y., et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005, 26:586-593.
65. Kerem E., Reisman J., Corey M., et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-1191.
66. Doershuk C.F., Stern R.C. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 1999, 115:782-787.
67. Milla C.E., Warwick W.J. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998, 113:1230-1234.
68. Liou T.G., Adler F.R., Fitzsimmons S.C., et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153:345-352.
69. Mayer-Hamblett N., Rosenfeld M., Emerson J., et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002, 166:1550-1555.
70. Vizza C.D., Yusen R.D., Lynch J.P., et al. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2000, 162:819-825.
71. Belkin R.A., Henig N.R., Singer L.G., et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006, 173:659-666.
72. Ellaffi M., Vinsonneau C., Coste J., et al. One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:158-164.
73. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991, 115:343-349.
74. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002, 40:780-788.
75. Galie N., Manes A., Negro L., et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009, 30:394-403.
76. Forfia P.R., Mathai S.C., Fisher M.R., et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 177:1364-1369.
77. Forfia P.R., Fisher M.R., Mathai S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006, 174:1034-1041.
78. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000, 161:487-492.
79. Chan K.M. Idiopathic pulmonary arterial hypertension and equity of donor lung allocation in the era of the lung allocation score: are we there yet?. Am J Respir Crit Care Med 2009, 180:385-387.
80. Arcasoy S.M., Christie J.D., Pochettino A., et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001, 120:873-880.
81. Shorr A.F., Davies D.B., Nathan S.D. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003, 124:922-928.
82. Meyer D.M., Bennett L.E., Novick R.J., et al. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001, 20:935-941.
83. Meyer D.M., Edwards L.B., Torres F., et al. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005, 79:950-957. [discussion: 957-8].
84. Thabut G., Christie J.D., Ravaud P., et al. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med 2009, 151:767-774.
85. Nathan S.D., Shlobin O.A., Ahmad S., et al. Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation. J Heart Lung Transplant 2010, 29:1165-1171.